OR2W3
Olfactory receptor 2W3
Also known as: OR2W3_HUMAN, OR2W3P, OR2W8P, OST718
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z3T1
- Gene
- OR2W3
- Ensembl
- ENSG00000238243
- Chromosome
- 1
- Canonical length
- 314 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
314 residues, UniProt reviewed canonical sequence.
>Q7Z3T1|OR2W3
1 MDGTNGSTQT HFILLGFSDR PHLERILFVV ILIAYLLTLV GNTTIILVSR LDPHLHTPMY
61 FFLAHLSFLD LSFTTSSIPQ LLYNLNGCDK TISYMGCAIQ LFLFLGLGGV ECLLLAVMAY
121 DRCVAICKPL HYMVIMNPRL CRGLVSVTWG CGVANSLAMS PVTLRLPRCG HHEVDHFLRE
181 MPALIRMACV STVAIEGTVF VLAVGVVLSP LVFILLSYSY IVRAVLQIRS ASGRQKAFGT
241 CGSHLTVVSL FYGNIIYMYM QPGASSSQDQ GMFLMLFYNI VTPLLNPLIY TLRNREVKGA
301 LGRLLLGKRE LGKELocalizationUniProt · AlphaFold · HPA
Whether an antibody against OR2W3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 12 nTPM
- thyroid gland: 5.9 nTPM
- hypothalamus: 2.3 nTPM
- cerebral cortex: 1.7 nTPM
- basal ganglia: 1.4 nTPM
- midbrain: 1.3 nTPM
Single-cell type
- erythrocytes: 0.4 nCPM
- late spermatids: 0.3 nCPM
- early spermatids: 0.1 nCPM
- erythrocyte progenitors: 0.1 nCPM
- undifferentiated spermatogonia: 0.1 nCPM
- adipocytes: 0 nCPM
Immune cell
- myeloid DC: 0.2 nTPM
- total PBMC: 0.2 nTPM
- eosinophil: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- hypothalamus: 14 nTPM
- pons: 10 nTPM
- midbrain: 8.7 nTPM
- medulla oblongata: 6.7 nTPM
- cerebral cortex: 4.9 nTPM
- thalamus: 4.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.77
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.66
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OR2W3 as an antibody target. Whether an autoantibody or antibody against OR2W3 could matter depends on whether native OR2W3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OR2W3 is annotated at the cell surface, where native OR2W3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OR2W3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...